全文获取类型
收费全文 | 8429篇 |
免费 | 507篇 |
国内免费 | 112篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 151篇 |
妇产科学 | 81篇 |
基础医学 | 1408篇 |
口腔科学 | 141篇 |
临床医学 | 691篇 |
内科学 | 1777篇 |
皮肤病学 | 481篇 |
神经病学 | 626篇 |
特种医学 | 518篇 |
外科学 | 1027篇 |
综合类 | 19篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 311篇 |
眼科学 | 192篇 |
药学 | 833篇 |
中国医学 | 143篇 |
肿瘤学 | 520篇 |
出版年
2024年 | 7篇 |
2023年 | 74篇 |
2022年 | 241篇 |
2021年 | 340篇 |
2020年 | 179篇 |
2019年 | 231篇 |
2018年 | 283篇 |
2017年 | 232篇 |
2016年 | 322篇 |
2015年 | 400篇 |
2014年 | 511篇 |
2013年 | 483篇 |
2012年 | 786篇 |
2011年 | 773篇 |
2010年 | 403篇 |
2009年 | 371篇 |
2008年 | 499篇 |
2007年 | 428篇 |
2006年 | 345篇 |
2005年 | 380篇 |
2004年 | 266篇 |
2003年 | 224篇 |
2002年 | 225篇 |
2001年 | 175篇 |
2000年 | 184篇 |
1999年 | 130篇 |
1998年 | 48篇 |
1997年 | 27篇 |
1996年 | 35篇 |
1995年 | 15篇 |
1994年 | 32篇 |
1993年 | 16篇 |
1992年 | 41篇 |
1991年 | 44篇 |
1990年 | 37篇 |
1989年 | 49篇 |
1988年 | 28篇 |
1987年 | 30篇 |
1986年 | 25篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1981年 | 9篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1971年 | 4篇 |
1970年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有9048条查询结果,搜索用时 15 毫秒
11.
Choe Seong Wook MD Cho Wan Ik MD Lee Chang Kyun MD † Seo Seong Jun MD 《Dermatologic surgery》2005,31(5):502-508
BACKGROUND: Masseteric muscle hypertrophy is an uncommon dition represented as a swelling of the masseter muscle. Recent reports have demonstrated the successful use of botulinum in the treatment of masseteric hypertrophy. OBJECTIVE: This study was a prospective trial to evaluate the effectiveness of botulinum toxin type A (Botox) in the treatment of masseteric muscle hypertrophy according to doses of 10, 20, and 30 U. MATERIALS AND METHODS: Twenty-two patients were referred to the dermatologic clinic for the management of masseteric muscle hypertrophy. Ultrasonographic measurements of the thickness of the masseter muscle were performed, and clinical photographs were taken before treatment and 1, 2, 3, 4, 6, and 9 months after the treatment. RESULTS. The median values of percentage reduction of muscle mass were 10.3%, 16.5%, 23.7%, 24.7%, 21.6%, 16.5% in the 10 U group; 11.9%, 18.8%, 24.8%, 27.7%, 26.7%, and 21.8% in the 20 U group; and 12.0%, 19.4%, 25.0%, 27.8%, 37.8%, and 24.1% in the 30 U group. CONCLUSION. The adequate dose of botulinum toxin type A for treatment of masseteric muscle hypertrophy should be above 20 U. The effect of botulinum toxin type A is maintained for at least 9 months as the treatment of masseteric muscle hypertrophy. 相似文献
12.
13.
Jong-Moon Lee Kun-Woo Park Woo-Keun Seo Moon Ho Park Changsu Han Inho Jo Sangmee Ahn Jo 《Movement disorders》2007,22(16):2446-2449
There have been a few studies and inconsistent results regarding the coincidence of Parkinson's disease (PD) and atherosclerotic diseases, such as cerebrovascular disease. Carotid intima-media thickness (IMT) is a known marker for subclinical atherosclerosis. The aim of this study was to investigate the carotid IMT between PD patients and controls. We studied 43 patients with PD and 86 matched controls. The carotid IMT in PD patients was significantly smaller than in controls (0.796 +/- 0.179 mm vs. 0.913 +/- 0.237 mm, P < 0.05). In multivariate analysis, the carotid IMT was inversely associated with the duration of levodopa medication and the severity of PD. These results suggest that PD patients have a lower risk of atherosclerosis. 相似文献
14.
15.
Toshihiro Seo Taketoshi Kajihara Toshiro Iijima 《Macromolecular chemistry and physics.》1987,188(6):1295-1304
The catalytic hydrolysis of phenyl esters in systems containing ß-cyclodextrin (ß-CD) and polyelectrolytes was investigated. Poly(methacrylic acid) was found to exhibit an inhibition effect on the hydrolysis, while poly(sodium styrenesulfonate) (NaPSS) shows a pronounced acceleration effect on the hydrolysis: the larger the molecular weight and the lower the degree of substitution, the greater is the acceleration effect. On the other hand, sodium ethylbenzenesulfonate and sodium dodecylbenzenesulfonate inhibit the reaction. The acceleration of the reaction in presence of NaPSS is attributed to the concentration of ß-CD and the substrate esters near to the chain of the macromolecule, through inclusion effects and hydrophobic interactions. 相似文献
16.
K Kondo R Seo M Naka T Kitagawa K Wakitani M Sakata H Kira T Okegawa A Kawasaki 《European journal of pharmacology》1989,163(2-3):253-261
The beneficial effects of an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, 7-[2 alpha,4 alpha-(dimethylmethano)-6 beta-(2-cyclopentyl-2 beta- hydroxyacetamido)-1 alpha-cyclohexyl]-5(Z)-heptenoic acid (ONO-3708) on thrombosis were examined. ONO-3708 at 0.1-3 microM inhibited the human platelet aggregation induced by thromboxane A2, prostaglandin H2, collagen, ADP (secondary phase) and epinephrine (secondary phase) without affecting prostanoid synthesis and the content of cyclic AMP in platelets. The in vivo effects, on coronary thrombosis in this case, were examined in two canine models. ONO-3708, 3 to 300 micrograms/kg i.v., prevented dose dependently the coronary thrombosis induced by partial obstruction of the coronary artery. ONO-3708, 3 micrograms/kg per min i.v., significantly prevented electrically stimulated coronary thrombosis without affecting systemic blood pressure and heart rate. These results indicate that the thromboxane A2/prostaglandin endoperoxide receptor could play an important role in the pathogenesis of thrombosis and that ONO-3708 may have therapeutic advantages in preventing thrombosis. 相似文献
17.
Koichiroh Nandate Kenji Muranaka Koichi Shinohara Kazuyoshi Ishida Hiroko Ishida Katsuhiro Seo Hiroshi Takeshita 《Journal of anesthesia》1997,11(2):117-120
We retrospectively reviewed the records of 250 consecutive patients undergoing coronary artery bypass graft surgery (CABG)
from January 1994 through January 1996 to determine the incidence of persistent postoperative neurological dysfunction after
CABG and to compare normothermic and moderate hypothermic cardiopulmonary bypass (CPB). Normothermic CPB was used in 128 patients
(36°–37°C) and hypothermic CPB (27°–28°C) in 122 patients. Postoperative neurological dysfunction included focal motor deficits,
delayed recovery of consciousness (>24h) after surgery, and seizures within 1 week postoperatively. Persistent neurological
dysfunction was diagnosed if complete resolution had not occurred within 10 days of surgery. The incidence of persistent postoperative
neurological dysfunction was 4.1% in the hypothermic CPB group and 2.3% in the normothermic CPB group. There were no statistically
significant differences between the two groups (P=NS). These results suggest that normothermic CPB did not increase the incidence of persistent postoperative neurological
dysfunction compared to hypothermic CPB. 相似文献
18.
Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. 总被引:2,自引:0,他引:2
T Ezaki Y Seo H Tomoda M Furusawa T Kanematsu K Sugimachi 《The British journal of surgery》1992,79(3):224-226
A partial hepatic resection was performed in 13 patients with chronic liver disease using intermittent hepatic inflow occlusion. Eleven patients had liver cirrhosis and two had chronic hepatitis. Seven patients were classified as Child's grade A and six as Child's grade B before operation. Dissection of the hepatic parenchyma was performed during intermittent inflow occlusion. The time of clamping and declamping was 10-20 min and 5-8 min, respectively. Postoperative data on liver function showed recovery to preoperative levels by about 10 days after operation. There were no life-threatening complications. These results indicate that intermittent hepatic inflow occlusion can be achieved easily and safely to allow non-anatomical resection in patients with chronic liver disease. 相似文献
19.
A 44-year-old housewife was found to have coarctation of the abdominal aorta secondary to Takayasu's arteritis. Since she also had mitral stenosis, possible etiological relation between Takayasu's arteritis and mitral stenosis is suspected. 相似文献
20.
J Yoshida T Wakabayashi M Mizuno K Sugita H Seo M Oshima M Tadokoro S Sakuma 《Neurologia medico-chirurgica》1992,32(3):125-129
Iodine-131-labeled G-22 monoclonal antibody F(ab')2 fragment reaching specifically with a glioma-associated surface glycoprotein was administered to 12 glioma patients to investigate its use in radioimaging of intracranial gliomas. No immediate or delayed side effects were attributable to antibody injection. Nine patients received the radiolabeled complex intravenously. The images of low-grade gliomas were generally poor and disappeared within 4 days. High-contrast images were obtained beyond the 7th day in high-grade gliomas except one case in the pineal region. Three patients received intraventricular or intratumoral administration. Clear images of all tumors were demonstrated from the 2nd until later than the 7th day. One patient with cerebrospinal fluid (CSF) dissemination of brainstem glioma demonstrated negative CSF cytology after intraventricular administration. 相似文献